Dr. Wei Li is a Founding Partner of WuXi Healthcare Ventures and Managing Partner of 6 Dimensions Capital. Prior to joining WuXi Healthcare Ventures, Dr. Li focused his efforts on healthcare and life science investment opportunities at Fidelity Biosciences, Fidelity Growth Partners Asia, and Baird Venture Partners. He also led drug discovery projects and technology licensing due diligence at Vertex Pharmaceuticals, a global biotechnology company located in Boston, MA. During his scientific research career, Dr. Li first-authored numerous scientific publications in journals including Science, Proceedings of the National Academy of Sciences (PNAS), and the Journal of Biological Chemistry.
Dr. Li received a B.S., with distinction, in Chemical Physics from the University of Science and Technology of China, a Ph.D. in Biochemistry and Mammalian Genetics from Harvard University, and an M.B.A. with a concentration in Finance, Accounting and Marketing from the Kellogg School of Management at Northwestern University, where he was elected to Beta Gamma Sigma, the academic business honor society.